Dirk de Ruysscher (D.K.M.)

Dr Dirk De Ruysscher earned his medical degree at the University of Leuven, Belgium, in 1986, and became Radiation Oncologist at the same university in 1991. In 1992, he obtained his PhD thesis at the University of Leuven on the influence of radiotherapy on immunity. Dr De Ruysscher’s current main research interests are immune therapy and prognostic models for toxicity.

Dr De Ruysscher is chairing the Division Maastro Clinical Research, chairing the Dutch Platform for Radiotherapy of Lung Cancer and is the coordinator of the biobank project at Maastro Clinic that was able to include around 10,000 patients for radiogenomic studies. He was or is the main PI of 10 phase I studies, 24 phase II and 8 phase III trials, dealing with individualized radiation-dose escalation, combining targeted agents with radiotherapy, the development of new PET tracers, molecular pathways involved in radiation damage, individualized radiotherapy, proton therapy, meta-analyses,
cost-effectiveness, radiomics, immune therapy and prophylactic cranial irradiation.

In 2019, Dr De Ruysscher received the ESTRO (European Society for Therapeutic Radiation Oncology) Claudius Regaud Gold Medal. He has published over 400 peer-reviewed Wi-1 papers (H-index 86) and chapters in several scientific books.

Dr De Ruysscher is full Professor of Radiation Oncology/Respiratory Oncology at the Maastricht University Medical Center, Maastricht, The Netherlands.